Sebela Ireland Ltd Drug Patent Portfolio

Sebela Ireland Ltd owns 5 orange book drugs protected by 17 US patents with Lotronex having the least patent protection, holding only 2 patents. And Naftin with maximum patent protection, holding 6 patents. Given below is the list of Sebela Ireland Ltd's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10166205 Topical compositions and methods for making and using same 31 Jan, 2033
Active
US10166206 Topical compositions and methods for making and using same 31 Jan, 2033
Active
US10695303 Topical compositions and methods for making and using same 31 Jan, 2033
Active
US10729667 Topical compositions and methods for making and using same 31 Jan, 2033
Active
US8778365 Topical compositions and methods for making and using same 31 Jan, 2033
Active
US9161914 Topical compositions and methods for making and using same 31 Jan, 2033
Active
US8658663 Method of treating thermoregulatory disfunction with paroxetine 06 Apr, 2029
Active
US8486456 Itraconazole compositions with improved bioavailability 03 Oct, 2028
Active
US8946251 Method of treating thermoregulatory dysfunction with paroxetine 04 Aug, 2026
Active
US9393237 Method of treating thermoregulatory dysfunction with paroxetine 04 Aug, 2026
Active
US7598271 Crystalline paroxetine methane sulfonate 04 May, 2025
Active
US6284770 Medicaments for the treatment of non-constipated female irritable bowel syndrome 05 Oct, 2018 Expired
US5874447 4-Phenylpiperidine compounds for treating depression 10 Jun, 2017 Expired
US6509038 Antifungal compositions with improved bioavailability 12 May, 2017 Expired
US7081255 Antifungal compositions with improved bioavailability 12 May, 2017 Expired
US8591948 Antifungal compositions with improved bioavailability 12 May, 2017 Expired
US5360800 Tetrahydro-1H-pyrido[4,3-b]indol-1-one derivatives 13 Jan, 2013 Expired


Given below is the list of recent legal activities going on the following drug patents of Sebela Ireland Ltd.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Yr, Small Entity 17 Jan, 2024 US10729667
Payment of Maintenance Fee, 8th Yr, Small Entity 03 Jan, 2024 US9393237
Payment of Maintenance Fee, 4th Yr, Small Entity 13 Dec, 2023 US10695303
Payment of Maintenance Fee, 8th Yr, Small Entity 05 Apr, 2023 US9161914
Payment of Maintenance Fee, 8th Yr, Small Entity 20 Jul, 2022 US8946251 (Litigated)
Payment of Maintenance Fee, 4th Yr, Small Entity 15 Jun, 2022 US10166205
Payment of Maintenance Fee, 4th Yr, Small Entity 15 Jun, 2022 US10166206
Payment of Maintenance Fee, 8th Yr, Small Entity 29 Dec, 2021 US8778365
Payment of Maintenance Fee, 8th Yr, Small Entity 11 Aug, 2021 US8658663 (Litigated)
Change in Power of Attorney (May Include Associate POA) 06 Jul, 2021 US10729667
Email Notification 06 Jul, 2021 US10729667
Change in Power of Attorney (May Include Associate POA) 02 Jul, 2021 US10166205
Change in Power of Attorney (May Include Associate POA) 02 Jul, 2021 US8658663 (Litigated)
Change in Power of Attorney (May Include Associate POA) 02 Jul, 2021 US10166206
Change in Power of Attorney (May Include Associate POA) 02 Jul, 2021 US9393237


Sebela Ireland Ltd's Drug Patent Litigations

Sebela Ireland Ltd's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jan 30, 2012, against patent number US8658663. The petitioner , challenged the validity of this patent, with Patricia Allison Tewes Richards as the respondent. Click below to track the latest information on how companies are challenging Sebela Ireland Ltd's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US8658663 January, 2012 Decision
(21 Oct, 2013)
Patricia Allison Tewes Richards


Sebela Ireland Ltd's Family Patents

Sebela Ireland Ltd drugs have patent protection in a total of 26 countries. It's US patent count contributes only to 31.9% of its total global patent coverage. 7 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Sebela Ireland Ltd Drug List

Given below is the complete list of Sebela Ireland Ltd's drugs and the patents protecting them.


1. Brisdelle

Brisdelle is protected by 5 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8658663 Method of treating thermoregulatory disfunction with paroxetine 06 Apr, 2029
(4 years from now)
Active
US8946251 Method of treating thermoregulatory dysfunction with paroxetine 04 Aug, 2026
(1 year, 9 months from now)
Active
US9393237 Method of treating thermoregulatory dysfunction with paroxetine 04 Aug, 2026
(1 year, 9 months from now)
Active
US7598271 Crystalline paroxetine methane sulfonate 04 May, 2025
(6 months from now)
Active
US5874447 4-Phenylpiperidine compounds for treating depression 10 Jun, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Brisdelle's drug page


2. Lotronex

Lotronex is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6284770 Medicaments for the treatment of non-constipated female irritable bowel syndrome 05 Oct, 2018
(6 years ago)
Expired
US5360800 Tetrahydro-1H-pyrido[4,3-b]indol-1-one derivatives 13 Jan, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lotronex's drug page


3. Naftin

Naftin is protected by 6 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10166205 Topical compositions and methods for making and using same 31 Jan, 2033
(8 years from now)
Active
US10166206 Topical compositions and methods for making and using same 31 Jan, 2033
(8 years from now)
Active
US10695303 Topical compositions and methods for making and using same 31 Jan, 2033
(8 years from now)
Active
US10729667 Topical compositions and methods for making and using same 31 Jan, 2033
(8 years from now)
Active
US8778365 Topical compositions and methods for making and using same 31 Jan, 2033
(8 years from now)
Active
US9161914 Topical compositions and methods for making and using same 31 Jan, 2033
(8 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Naftin's drug page


4. Onmel

Onmel is protected by 4 patents, out of which 3 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8486456 Itraconazole compositions with improved bioavailability 03 Oct, 2028
(3 years from now)
Active
US6509038 Antifungal compositions with improved bioavailability 12 May, 2017
(7 years ago)
Expired
US7081255 Antifungal compositions with improved bioavailability 12 May, 2017
(7 years ago)
Expired
US8591948 Antifungal compositions with improved bioavailability 12 May, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Onmel's drug page


5. Pexeva

Pexeva is protected by 2 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7598271 Crystalline paroxetine methane sulfonate 04 May, 2025
(6 months from now)
Active
US5874447 4-Phenylpiperidine compounds for treating depression 10 Jun, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Pexeva's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List